Mylan (MYL) Launches Perphenazine, a Generic Version of Trilafon Tablets
Tweet Send to a Friend
Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
